Connection

Donald Castell to Double-Blind Method

Back to Details
This is a "connection" page, showing publications Donald Castell has written about Double-Blind Method.
Donald Castell
Connection Strength
0.774
Double-Blind Method
  1. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression. Pharmacotherapy. 2015 Dec; 35(12):1124-9.
    View in: PubMed
    Score: 0.097
  2. Arbaclofen placarbil decreases postprandial reflux in patients with gastroesophageal reflux disease. Am J Gastroenterol. 2010 Jun; 105(6):1266-75.
    View in: PubMed
    Score: 0.064
  3. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers. J Clin Gastroenterol. 2009 Mar; 43(3):253-60.
    View in: PubMed
    Score: 0.061
  4. Effects of a 5-HT(4) receptor agonist on oesophageal function and gastro-oesophageal reflux: studies using combined impedance-manometry and combined impedance-pH. Aliment Pharmacol Ther. 2006 Jul 01; 24(1):155-62.
    View in: PubMed
    Score: 0.051
  5. Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers. Aliment Pharmacol Ther. 2002 Apr; 16(4):829-36.
    View in: PubMed
    Score: 0.038
  6. Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors. Aliment Pharmacol Ther. 2002 Mar; 16(3):473-7.
    View in: PubMed
    Score: 0.037
  7. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol. 2002 Mar; 97(3):575-83.
    View in: PubMed
    Score: 0.037
  8. Cisapride 20 mg b.d. for preventing symptoms of GERD induced by a provocative meal. The CIS-USA-89 Study Group. Aliment Pharmacol Ther. 1999 Jun; 13(6):787-94.
    View in: PubMed
    Score: 0.031
  9. Bedtime ranitidine does not eliminate the need for a second daily dose of omeprazole to suppress nocturnal gastric pH. Aliment Pharmacol Ther. 1999 May; 13(5):675-8.
    View in: PubMed
    Score: 0.031
  10. Effects of octreotide on esophageal visceral perception and cerebral evoked potentials induced by balloon distension. Am J Gastroenterol. 1999 Jan; 94(1):65-70.
    View in: PubMed
    Score: 0.030
  11. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology. 1998 Dec; 115(6):1335-9.
    View in: PubMed
    Score: 0.030
  12. Imipramine decreases oesophageal pain perception in human male volunteers. Gut. 1998 Jun; 42(6):807-13.
    View in: PubMed
    Score: 0.029
  13. Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci. 1997 Oct; 42(10):2138-45.
    View in: PubMed
    Score: 0.028
  14. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy. Am J Gastroenterol. 1997 Mar; 92(3):429-37.
    View in: PubMed
    Score: 0.026
  15. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group. Am J Gastroenterol. 1996 Sep; 91(9):1749-57.
    View in: PubMed
    Score: 0.026
  16. A comparison of the effect of olestra and triglyceride on postprandial esophageal acid exposure. Am J Gastroenterol. 1993 Oct; 88(10):1734-7.
    View in: PubMed
    Score: 0.021
  17. Effects of nifedipine on esophageal tone and perception of esophageal distension. Dig Dis Sci. 1992 Apr; 37(4):598-602.
    View in: PubMed
    Score: 0.019
  18. Randomized, double-blind, placebo-controlled crossover trial of pirenzepine in patients with gastroesophageal reflux. Dig Dis Sci. 1992 Feb; 37(2):297-302.
    View in: PubMed
    Score: 0.019
  19. Oral nifedipine in the treatment of noncardiac chest pain in patients with the nutcracker esophagus. Gastroenterology. 1987 Jul; 93(1):21-8.
    View in: PubMed
    Score: 0.014
  20. Effectiveness of foaming antacid in relieving induced heartburn. South Med J. 1986 Mar; 79(3):327-30.
    View in: PubMed
    Score: 0.012
  21. Nifedipine: a potent inhibitor of contractions in the body of the human esophagus. Studies in healthy volunteers and patients with the nutcracker esophagus. Gastroenterology. 1985 Sep; 89(3):549-54.
    View in: PubMed
    Score: 0.012
  22. Intragastric acid suppression and pharmacokinetics of twice-daily esomeprazole: a randomized, three-way crossover study. Aliment Pharmacol Ther. 2004 Aug 15; 20(4):399-406.
    View in: PubMed
    Score: 0.011
  23. Esophageal bougienage in symptomatic patients with the nutcracker esophagus. A primary esophageal motility disorder. JAMA. 1984 Jul 20; 252(3):363-6.
    View in: PubMed
    Score: 0.011
  24. Esomeprazole resolves chronic heartburn in patients without erosive oesophagitis. Aliment Pharmacol Ther. 2003 Nov 01; 18(9):875-82.
    View in: PubMed
    Score: 0.011
  25. The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2000 Nov; 14(11):1503-9.
    View in: PubMed
    Score: 0.009
  26. Health-related quality of life of patients with acute erosive reflux esophagitis. Dig Dis Sci. 1996 Nov; 41(11):2123-9.
    View in: PubMed
    Score: 0.006
  27. Diltiazem therapy for symptoms associated with nutcracker esophagus. Am J Gastroenterol. 1991 Mar; 86(3):272-6.
    View in: PubMed
    Score: 0.004
  28. Multicenter trial of sucralfate suspension for the treatment of reflux esophagitis. Am J Med. 1987 Sep 28; 83(3B):61-6.
    View in: PubMed
    Score: 0.003
  29. Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage. Am J Med. 1987 Sep 28; 83(3B):74-82.
    View in: PubMed
    Score: 0.003
  30. Efficacy of atropine as an endoscopic premedication. Gastrointest Endosc. 1983 Nov; 29(4):285-8.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.